New hope for kidney patients: diabetes drugs tested for nephrotic syndrome
NCT ID NCT07214818
First seen Oct 31, 2025 · Last updated Apr 29, 2026 · Updated 21 times
Summary
This study tests whether two diabetes drugs (dapagliflozin and empagliflozin) can help adults with nephrotic syndrome, a kidney condition causing protein leakage and swelling. 75 participants will receive either one of the drugs plus standard care, or standard care alone, and be followed for 6 months. The goal is to see if these drugs reduce protein in urine, maintain remission, and prevent relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Urology & Nephrology Center, Mansoura University
Al Mansurah, Dakahlia Governorate, 35516, Egypt
Conditions
Explore the condition pages connected to this study.